Geron Corp. (GERN)
1.52
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
1.52
0.00 (0.00%)
After-Hours: 20:00
Geron 1 Year Total Returns (Daily) : 6.29% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 6.29% |
| August 20, 2026 | 11.51% |
| August 19, 2026 | 11.19% |
| August 18, 2026 | 6.25% |
| August 17, 2026 | 5.52% |
| August 14, 2026 | 1.38% |
| August 13, 2026 | 7.34% |
| August 12, 2026 | 16.30% |
| August 11, 2026 | 19.85% |
| August 10, 2026 | 15.62% |
| August 07, 2026 | 13.85% |
| August 06, 2026 | 12.95% |
| August 05, 2026 | 35.83% |
| August 04, 2026 | 10.74% |
| August 03, 2026 | 9.40% |
| July 31, 2026 | 12.17% |
| July 30, 2026 | 21.82% |
| July 29, 2026 | 23.35% |
| July 28, 2026 | 26.09% |
| July 27, 2026 | 17.46% |
| July 24, 2026 | 10.94% |
| July 23, 2026 | 9.02% |
| July 22, 2026 | 10.16% |
| July 21, 2026 | 17.07% |
| July 20, 2026 | 16.13% |
| Date | Value |
|---|---|
| July 17, 2026 | 11.63% |
| July 16, 2026 | 11.81% |
| July 15, 2026 | 12.70% |
| July 14, 2026 | 2.99% |
| July 13, 2026 | 7.58% |
| July 10, 2026 | 8.70% |
| July 09, 2026 | 8.33% |
| July 08, 2026 | 12.23% |
| July 07, 2026 | 8.76% |
| July 06, 2026 | 0.70% |
| July 02, 2026 | -2.86% |
| July 01, 2026 | -7.97% |
| June 30, 2026 | -9.22% |
| June 29, 2026 | -12.75% |
| June 26, 2026 | -13.73% |
| June 25, 2026 | -9.87% |
| June 24, 2026 | -10.65% |
| June 23, 2026 | -4.93% |
| June 22, 2026 | -11.26% |
| June 18, 2026 | -18.71% |
| June 17, 2026 | -15.17% |
| June 16, 2026 | -23.87% |
| June 15, 2026 | -23.84% |
| June 12, 2026 | -26.28% |
| June 11, 2026 | -25.97% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Precigen, Inc. | 97.80% |
| Editas Medicine, Inc. | 13.92% |
| Agenus, Inc. | 77.02% |
| Amgen, Inc. | 53.88% |
| Anika Therapeutics, Inc. | 140.7% |